Fineline Cube

Follow:
14433 Articles
Everest Medicines' Velsipity NDA Accepted for Review in Taiwan
CompanyDrug

Everest Medicines’ Velsipity NDA Accepted for Review in Taiwan

Hualan Biological Gains NMPA Approval for Hib Vaccine Clinical Trials
CompanyDrug

Hualan Biological Gains NMPA Approval for Hib Vaccine Clinical Trials

RemeGen Announces Positive Phase III Results for Telitacicept in Primary Sjögren's Syndrome
CompanyDrug

RemeGen Announces Positive Phase III Results for Telitacicept in Primary Sjögren’s Syndrome

China Issues Guidelines for Medical Advertisement Identification, Clarifies Scenarios and Regulations
HospitalMedical Device

China Issues Guidelines for Medical Advertisement Identification, Clarifies Scenarios and Regulations

MSD Officially Launches Zerbaxa in China to Tackle Drug-Resistant Infections
CompanyDrug

MSD Officially Launches Zerbaxa in China to Tackle Drug-Resistant Infections

Jiangsu Hengrui Establishes New Biopharmaceutical Unit to Strengthen Anesthesia and ICU Presence
Company

Jiangsu Hengrui Establishes New Biopharmaceutical Unit to Strengthen Anesthesia and ICU Presence

Jiangsu Hengrui's Combo Therapy Approved for Clinical Trials by NMPA
CompanyDrug

Jiangsu Hengrui’s Combo Therapy Approved for Clinical Trials by NMPA

Henlius Biotech's HLX04-O Accepted by NMPA for Wet AMD Treatment
CompanyDrug

Henlius Biotech’s HLX04-O Accepted by NMPA for Wet AMD Treatment

TYK Medicines' Asandeutertinib Shows Promising Results in Phase II Trial for EGFR-Mutated NSCLC
CompanyDrug

TYK Medicines’ Asandeutertinib Shows Promising Results in Phase II Trial for EGFR-Mutated NSCLC

CANbridge Pharmaceuticals Secures HK 100 Million Equity Financing From Baheal Pharma
CompanyDeals

CANbridge Pharmaceuticals Secures HK 100 Million Equity Financing From Baheal Pharma

Kangji Medical Proposes Privatization, Aiming to Delist from Hong Kong Stock Exchange
CompanyDeals

Kangji Medical Proposes Privatization, Aiming to Delist from Hong Kong Stock Exchange

Hengrui Pharmaceuticals Expands Hetrombopag Olamine's Indication for ITP Patients
CompanyDrug

Hengrui Pharmaceuticals Expands Hetrombopag Olamine’s Indication for ITP Patients